Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peritoneal Neoplasms 2Mesothelioma, Malignant 2Adrenocortical Carcinoma 2Thrombocytopenia 1Stomach Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoma 1Laryngeal Neoplasms 1Intraocular Lymphoma 1Hypopharyngeal Neoplasms 1Hyperthermia 1Glioma 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Carcinoma 1Adenocarcinoma 1

Interventions

Oxaliplatin 10Capecitabine 9Cisplatin 8Fluorouracil 5Leucovorin 4Bevacizumab 4tegafur-gimeracil-oteracil 3pemigatinib 3atezolizumab 3Nivolumab 3trebananib 2ponatinib 2pembrolizumab 2avelumab 2apatinib 2alectinib 2XELOX 2Standard of Care 2S 1 (combination) 2Radiotherapy 2Radiosurgery 2Ocoxin 2Irinotecan 2Ipilimumab 2Gemcitabine 2Folfox protocol 2Everolimus 2Erlotinib Hydrochloride 2Acupuncture Therapy 2zanidatamab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Gastrointestinal Neoplasms × sodium thiosulfate × Clear all
NCT02092298 2021-06-15

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
21 enrolled 7 charts
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡